Shanghai INT Medical Instruments Co (HKSE:01501) Beneish M-Score: -2.56 (As of Jul. 19, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:01501 Shanghai INT Medical Instruments Co Ltd HKSE:01501
93 GF Score
Price HK$32.90
GF Value HK$39.95
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is Shanghai INT Medical Instruments Co Beneish M-Score?

Shanghai INT Medical Instruments Co HKSE:01501 -0.66% 93 Beneish M-Score is -2.56 as of Jul. 19, 2026. GuruFocus rates HKSE:01501 with a GF Score™ of 93/100 and a GF Value™ of HK$39.95 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 762 Medical Devices & Instruments companies, Shanghai INT Medical Instruments Co ranks worse than 53.28% on this metric.

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -2.56 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Shanghai INT Medical Instruments Co's Beneish M-Score or its related term are showing as below:

HKSE:01501' s Beneish M-Score Range Over the Past 10 Years
Min: -2.91   Med: -2.26   Max: -0.41
Current: -2.56

During the past 10 years, the highest Beneish M-Score of Shanghai INT Medical Instruments Co was -0.41. The lowest was -2.91. And the median was -2.26.


Shanghai INT Medical Instruments Co Beneish M-Score Historical Data

* Premium members only.

The historical data trend for Shanghai INT Medical Instruments Co's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shanghai INT Medical Instruments Co Beneish M-Score Chart

Shanghai INT Medical Instruments Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.41 -2.75 -1.96 -2.77 -2.56

Shanghai INT Medical Instruments Co Semi-Annual Data
Dec16 Dec17 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.96 0.00 -2.77 0.00 -2.56

HKSE:01501 vs ISRG, BDX, MDLN: Beneish M-Score Comparison

For the Medical Instruments & Supplies subindustry, Shanghai INT Medical Instruments Co's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shanghai INT Medical Instruments Co Beneish M-Score vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Shanghai INT Medical Instruments Co's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Shanghai INT Medical Instruments Co's Beneish M-Score falls into.


HKSE:01501
93GF Score
Shanghai INT Medical Instruments Co Ltd HKSE:01501
Beneish M-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Shanghai INT Medical Instruments Co Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Shanghai INT Medical Instruments Co for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 0.7541+0.528 * 1.0559+0.404 * 1.6744+0.892 * 1.294+0.115 * 0.811
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 1.0624+4.679 * -0.041292-0.327 * 1.601
=-2.56

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec25) TTM:Last Year (Dec24) TTM:
Total Receivables was HK$124 Mil.
Revenue was HK$1,177 Mil.
Gross Profit was HK$703 Mil.
Total Current Assets was HK$1,130 Mil.
Total Assets was HK$3,460 Mil.
Property, Plant and Equipment(Net PPE) was HK$946 Mil.
Depreciation, Depletion and Amortization(DDA) was HK$115 Mil.
Selling, General, & Admin. Expense(SGA) was HK$294 Mil.
Total Current Liabilities was HK$895 Mil.
Long-Term Debt & Capital Lease Obligation was HK$208 Mil.
Net Income was HK$242 Mil.
Gross Profit was HK$0 Mil.
Cash Flow from Operations was HK$385 Mil.
Total Receivables was HK$127 Mil.
Revenue was HK$910 Mil.
Gross Profit was HK$574 Mil.
Total Current Assets was HK$953 Mil.
Total Assets was HK$2,413 Mil.
Property, Plant and Equipment(Net PPE) was HK$884 Mil.
Depreciation, Depletion and Amortization(DDA) was HK$85 Mil.
Selling, General, & Admin. Expense(SGA) was HK$214 Mil.
Total Current Liabilities was HK$464 Mil.
Long-Term Debt & Capital Lease Obligation was HK$17 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(123.866 / 1177.059) / (126.926 / 909.607)
=0.105233 / 0.139539
=0.7541

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(574.047 / 909.607) / (703.475 / 1177.059)
=0.631093 / 0.597655
=1.0559

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (1129.946 + 946.412) / 3459.946) / (1 - (952.505 + 884.083) / 2412.812)
=0.399887 / 0.238818
=1.6744

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=1177.059 / 909.607
=1.294

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(85.269 / (85.269 + 884.083)) / (115.141 / (115.141 + 946.412))
=0.087965 / 0.108465
=0.811

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(293.908 / 1177.059) / (213.781 / 909.607)
=0.249697 / 0.235026
=1.0624

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((207.544 + 895.431) / 3459.946) / ((16.575 + 463.857) / 2412.812)
=0.318784 / 0.199117
=1.601

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(241.698 - 0 - 384.566) / 3459.946
=-0.041292

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Shanghai INT Medical Instruments Co has a M-score of -2.56 suggests that the company is unlikely to be a manipulator.

Frequently Asked Questions Learn more about Beneish M-Score →
What does a Beneish M-Score of -2.56 mean?
Shanghai INT Medical Instruments Co (HKSE:01501) has a Beneish M-Score of -2.56 as of Jul. 19, 2026. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Shanghai INT Medical Instruments Co and its competitors. According to the industry distribution chart, Shanghai INT Medical Instruments Co ranks #406 out of 762 companies in the Medical Devices & Instruments industry, placing it in the top 53.3%.
Is Shanghai INT Medical Instruments Co's Beneish M-Score too high?
Shanghai INT Medical Instruments Co's current Beneish M-Score is -2.56. Based on the distribution chart, Shanghai INT Medical Instruments Co ranks #406 out of 762 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Shanghai INT Medical Instruments Co has a GF Score™ of 93/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Shanghai INT Medical Instruments Co's Beneish M-Score compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Shanghai INT Medical Instruments Co ranks #406 out of 762 companies for Beneish M-Score. This places Shanghai INT Medical Instruments Co in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beneish M-Score for a Medical Devices & Instruments company?
A good Beneish M-Score depends on the Medical Devices & Instruments industry context. However, Beneish M-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beneish M-Score mean?
A high Beneish M-Score can signal that a stock is expensive relative to its fundamentals. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Shanghai INT Medical Instruments Co and its competitors. Shanghai INT Medical Instruments Co's current Beneish M-Score is -2.56. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shanghai INT Medical Instruments Co stock overvalued right now?
Based on GuruFocus' analysis, Shanghai INT Medical Instruments Co (HKSE:01501) is currently considered Modestly Undervalued. The stock's GF Value™ is HK$39.95, compared to a current price of HK$32.90 — trading 17.6% below its estimated fair value. The current Beneish M-Score is -2.56. Shanghai INT Medical Instruments Co's overall GF Score™ is 93/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beneish M-Score calculated?
Beneish M-Score is calculated from a company's financial statements. For Shanghai INT Medical Instruments Co (HKSE:01501), the current Beneish M-Score is -2.56 as of Jul. 19, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Shanghai INT Medical Instruments Co (HKSE:01501) Overvalued in 2026?

Based on GuruFocus' analysis, Shanghai INT Medical Instruments Co stock appears to be undervalued. The current stock price of HK$32.90 is trading 17.6% below its estimated GF Value™ of HK$39.95. GuruFocus considers Shanghai INT Medical Instruments Co to be Modestly Undervalued.

Key valuation signals for HKSE:01501:

  • Beneish M-Score: -2.56
  • GF Value™: HK$39.95 vs. price of HK$32.90 (17.6% below fair value)
  • GF Score™: 93/100 with 4 warning signs

No single metric tells the full story. See the HKSE:01501 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Shanghai INT Medical Instruments Co Business Description

Address No. 925 Jin Yuan Yi Road, Block 2, Jiading District, Shanghai, CHN, 201803
Shanghai INT Medical Instruments Co Ltd engages in the design and development of medical devices used in fields including peripheral intervention, neurological intervention, cardiovascular intervention, or implantation, and the design and development of equipment and moulds used for the production of medical devices. The company operates in the Chinese Mainland, Europe, the United States, and Other countries and regions. The majority of the revenue comes from the Chinese Mainland.
93GF Score

Get the complete analysis for HKSE:01501

Beneish M-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$32.90
Price
HK$39.95
GF Value